Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells

Haifa Shen, Tong Sun, Hanh H. Hoang, Jana S. Burchfield, Gillian F. Hamilton, Elizabeth A. Mittendorf, Mauro Ferrari

Research output: Contribution to journalReview article

16 Scopus citations

Abstract

Cancer immunotherapy has become arguably the most promising advancement in cancer research and therapy in recent years. The efficacy of cancer immunotherapy is critically dependent on specific physiological and physical processes – collectively referred to as transport barriers – including the activation of T cells by antigen presenting cells, T cells migration to and penetration into the tumor microenvironment, and movement of nutrients and other immune cells through the tumor microenvironment. Nanotechnology-based approaches have great potential to help overcome these transport barriers. In this review, we discuss the ways that nanotechnology is being leveraged to improve the efficacy and potency of various cancer immunotherapies.

Original languageEnglish (US)
Pages (from-to)114-122
Number of pages9
JournalSeminars in Immunology
Volume34
DOIs
StatePublished - Dec 2017

Keywords

  • Cancer immunotherapy
  • Nanotechnology
  • Tumor microenvironment
  • Tumor-infiltrating lymphocytes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells'. Together they form a unique fingerprint.

Cite this